Skip to content

To study the safety and performance of implants used for radius head replacement in patients with elbow fracture

Post Market Clinical Follow-up (PMCF) study to evaluate the safety and performance of Radial Head System - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100841
Enrollment
30
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S479- Crushing injury of shoulder and upper arm, unspecified arm

Interventions

Intervention1: Radial head replacement: Radial head replacement shall be done at baseline and patients shall be followed up for two years. Control Intervention1: None: N.A.

Sponsors

Auxein Medical Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with non-reconstructible radial head fractures.

Exclusion criteria

Exclusion criteria: 1. Patients will known metabolic bone disease. 2. Patients having inadequate tissue coverage over the operative site. 3. Suspected or documented allergy or intolerance to implant materials. 4. Patients with symptomatic arthritis. 5. Severely comminuted fractures. 6. Prominent neurological condition that would interfere with physiotherapy. 7. Known psychiatric disease that would interfere with study participation. 8. Pregnant women or those planning pregnancy.

Design outcomes

Primary

MeasureTime frame
1. Rate of implant survivorship. 2. Complications including SAEs. Timepoint: 6 Week 3 Month 6 Month 12 Month 24 Month

Secondary

MeasureTime frame
1. Improvement in patient reported outcomes. 2. Range of motion.Timepoint: 6 Week 3 Month 6 Month 12 Month 24 Month

Countries

India

Contacts

Public ContactDr Mohd Aslam

Auxein Medical Pvt Ltd

m.aslam@auxeinmedical.com7419660141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026